APA (7th ed.) Citation

Sepah, Y. J., Sadiq, M. A., Boyer, D., Callanan, D., Gallemore, R., Bennett, M., . . . Do, D. V. (2016). Twenty-four-Month Outcomes of the Ranibizumab for Edema of the Macula in Diabetes - Protocol 3 with High Dose (READ-3) Study. Ophthalmology (Rochester, Minn.), 123(12), 2581. https://doi.org/10.1016/j.ophtha.2016.08.040

Chicago Style (17th ed.) Citation

Sepah, Yasir J., et al. "Twenty-four-Month Outcomes of the Ranibizumab for Edema of the Macula in Diabetes - Protocol 3 with High Dose (READ-3) Study." Ophthalmology (Rochester, Minn.) 123, no. 12 (2016): 2581. https://doi.org/10.1016/j.ophtha.2016.08.040.

MLA (9th ed.) Citation

Sepah, Yasir J., et al. "Twenty-four-Month Outcomes of the Ranibizumab for Edema of the Macula in Diabetes - Protocol 3 with High Dose (READ-3) Study." Ophthalmology (Rochester, Minn.), vol. 123, no. 12, 2016, p. 2581, https://doi.org/10.1016/j.ophtha.2016.08.040.